Ablynx looks to GSK for new chief commercial officer
November 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, johan heylan
Belgium-based biopharma firm Ablynx has appointed Johan Heylen to be its chief commercial officer and assume responsibility for all commercial …
Global drug spending set to top $1 trillion
November 20, 2014Sales and Marketing Gilead, IMS, Kadcyla, Perjeta, drugs, hepatitis C, sovaldi, spend
Worldwide spending on drugs will reach over $1 trillion in 2014 and $1.3 trillion by 2018, according to a new …
Gilead gets Harvoni boost for Europe
November 20, 2014Sales and Marketing EU, Gilead, HCV, harvoni, hepc, ledipasvir, sofosbuvir, svaldi
Gilead Sciences’ new hepatitis C (HCV) tablet Harvoni has been approved across the European Union to treat the majority of …
Sanofi showcases alirocumab at AHA
November 20, 2014Sales and Marketing Amgen, PCSK9, Regeneron, Sanofi, aha, alirocumab, evolocumab
Sanofi and Regeneron released a battery of new Phase III data on their PCSK9 inhibitor alirocumab this week, reinforcing the …
NICE aims for earlier cancer diagnosis
November 20, 2014Sales and Marketing Cancer, England, NHS, NICE, OECD, UK, baker
NICE is updating its guidance in a bid to help doctors spot the signs and symptoms of cancer as part …
Sanofi names new board member
November 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, bonnie bassler
Sanofi has appointed Professor Bonnie Bassler as an independent member to sit among its board of directors. Bassler has more …
GSK tests mHealth trial solutions
November 19, 2014Medical Communications, Sales and Marketing Apple, GSK, Medidata, dr Vries, healthpatch, mhealth
GlaxoSmithKline is experimenting with mobile health (mHealth) devices linked to cloud services in clinical trials as part of a bid …
AZ predicts strong growth ahead of Pfizer deadline
November 19, 2014Sales and Marketing AZD9291, AstraZeneca, Pfizer, Soriot, definiens
AstraZeneca has announced that it expects to deliver revenues of over $45 billion by 2023 as it makes its final …
Reckitt finalises pharmaceutical demerger plans
November 19, 2014Business Services, Sales and Marketing Reckitt Benckiser Pharmaceuticals, cillit bang, indivior, suboxone
Reckitt Benckiser has confirmed its plans to spin-off its pharmaceutical portfolio from its core consumer products business. Final details of …
Europe must prepare for COPD ‘timebomb’
November 19, 2014Sales and Marketing COPD, Europe, European COPD Coalition, Spiriva, asthma, chronic obstructive pulmonary disease
Health services in Europe are not making sufficient effort to cope with the escalating burden of chronic obstructive pulmonary disease …
NICE wants more Xolair data
November 19, 2014Sales and Marketing Genentech, NHS, NICE, Novartis, UK, Xolair, hives, omalizumab
Novartis has been asked in draft guidance to give NICE more information before the watchdog can recommend its veteran asthma …
Sanofi appoints an Ebola response co-ordinator
November 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ebola, Sanofi, gary nobel
Former director of the NIH Vaccine Research Center Dr Gary Nabel has been hired by Sanofi to spearhead its contribution …
European Medicines Agency appoints admin lead
November 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Luc Vanheel, admin
Luc Vanheel has joined the European Medicines Agency (EMA) as the head of its administration division. A Belgian national, Vanheel …
Pfizer signs $3 billion cancer deal
November 18, 2014Research and Development, Sales and Marketing Cancer, Merck KGaA, PD-L1, Pfizer, anti-PD-L1, opdivo
Pfizer has signed a multi-billion dollar deal to develop one of Merck KGaA’s investigational drugs, MSB0010718C, an anti-PD-L1 antibody. The …
Creston Health rebrands as Health Unlimited
November 18, 2014Medical Communications Astellas, Creston, Red Door, health unlimited, warne
Marketing communications group Creston has announced that its Creston Health arm will now be rebranded as Health Unlimited. Under the …
Antibiotic resistance ranking high among public concerns
November 18, 2014Research and Development, Sales and Marketing Antibiotics, Cameron, WHO, longitude, rees, terrorism
People in the UK believe antibiotic resistance is second only to terrorism among threats to the public, according to a …
Actavis buys Allergan for $66 billion
November 18, 2014Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Canada, Valeant, merger
The stately dance between Actavis and Allergan has culminated in the former buying the Botox manufacturer in a $66 billion …
New head of industrial operations at Bayer
November 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Klaus Schäfer
Bayer MaterialScience is getting a new head of industrial operations and technology as Dr Tony Van Osselaer retires from the …
Synergy Vision’s Ffyona Dawber wins Gold and Silver at the 2014 Stevie Awards for Women in Business
November 17, 2014Medical Communications Stevie awards, Synergy Vision, medical communications agency
Ffyona Dawber has scooped two prestigious Stevie® Awards at the 11th annual Stevie Awards for Women in Business held in …
GSK tops pharma league for access
November 17, 2014Sales and Marketing Africa, GSK, Novo Nordisk, access, market, vaccines
GlaxoSmithKline is basking in some good news after topping the league table of pharma companies which do the most to …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
Alcami appoints Will Isom to lead laboratory services sales
